Modeling and simulation at the FDA and in industry: collaboration among statisticians, modelers and pharmacometricians
*Vikram Sinha, FDA 

Keywords:

The talk will address the role of model-based approaches and model-informed regulatory assessments in drug development from a pharmacometric regulatory perspective with highlights on the collaboration between industry and the FDA.